The reproductive function of patients with prior atypical endometrial hyperplasia and endometrial cancer treatment: cohort study
- Authors: Dzhanashvili L.G.1, Khachatryan N.A.1, Nazarenko T.A.1, Biriukova A.M.1, Dmitrieva I.E.1
-
Affiliations:
- Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
- Issue: Vol 24, No 4 (2022)
- Pages: 277-282
- Section: ORIGINAL ARTICLE
- URL: https://journal-vniispk.ru/2079-5831/article/view/108121
- DOI: https://doi.org/10.26442/20795696.2022.4.201670
- ID: 108121
Cite item
Full Text
Abstract
Aim. To define the management of realization of reproductive function implementation in patients experienced atypical endometrial hyperplasia and endometrial cancer IA stage.
Materials and methods. 150 patients aged 21–42 years were included. Among them 78 patients with atypical endometrial hyperplasia (group 1) and 72 – with endometrial cancer IA stage (group 2). General clinical, anamnestic and laboratory examination and follow-up with monitoring of gonadotropins and steroid hormones, as well as pelvic ultrasound supplemented with outcomes of reproductive function and in vitro fertilization (IVF) programs.
Results. It was shown a possibility of spontaneous pregnancy in young patients with regular cycles without other infertility factors with pathomorfosis 2–3 stages and the endometrial receptivity. The practicability of IVF-programs with frozen oocytes and embryo transfer in young women with a lower ovarian reserve and high-risk cancer relapse was demonstrated when their reproductive plan was uncertain.
Conclusion. The reproductive function in patients who experienced atypical endometrial hyperplasia and endometrial cancer IA stage might be realized through a personified approach using assisted reproductive technologies and modified IVF-programs with frozen oocytes and embryo transfer.
Full Text
##article.viewOnOriginalSite##About the authors
Lana G. Dzhanashvili
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Author for correspondence.
Email: lana.janashvili@gmail.com
ORCID iD: 0000-0002-2891-3974
Cand. Sci. (Med.)
Russian Federation, MoscowNelly A. Khachatryan
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Email: lana.janashvili@gmail.com
ORCID iD: 0000-0001-6833-1787
Cand. Sci. (Med.)
Russian Federation, MoscowTat'iana A. Nazarenko
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Email: lana.janashvili@gmail.com
ORCID iD: 0000-0002-5823-1667
D. Sci. (Med.), Prof.
Russian Federation, MoscowAl'mina M. Biriukova
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Email: lana.janashvili@gmail.com
Cand. Sci. (Med.)
Russian Federation, MoscowIrina E. Dmitrieva
Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology
Email: lana.janashvili@gmail.com
ORCID iD: 0000-0001-5119-3816
Graduate Student
Russian Federation, MoscowReferences
- Emons G, Beckmann MW, Schmidt D, et al. Uterus commission of the Gynecological Oncology Working Group (AGO). New WHO Classification of Endometrial Hyperplasias. Geburtshilfe Frauenheilkd. 2015;75(2):135-6. doi: 10.1055/s-0034-1396256
- Злокачественные новообразования в России в 2017 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2018 [Zlokachestvennye novoobrazovaniia v Rossii v 2017 godu (zabolevaemost' i smertnost'). Pod red. AD Kaprina, VV Starinskogo, GV Petrovoi. Moscow: MNIOI im. PA Gertsena – filial FGBU «NMITs radiologii» Minzdrava Rossii, 2018 (in Russian)].
- Сушинская Т.В., Жорданиа К.И., Паяниди Ю.Г. Аналитические аспекты онкологических заболеваний женского населения России. Онкогинекология. 2015;3:40-3 [Sushinskaya TV, Zhordania KI, Payanidi YuG. Analytical aspects of oncological diseases of the female population of Russia. Gynecologic Oncology. 2015;3:40-3 (in Russian)].
- Клинические рекомендации. Рак тела матки и саркомы матки. М.: Минздрав России, 2021. Режим доступа: https://rrcrst.ru/content/klinicheskie-rekomendaczii/%D0%A0%D0%B0%D0%BA%20%D1%82%D0%B5%D0%BB%D0%B0%20%D0%BC%D0%B0%D1%82%D0%BA%D0%B8%20%D0%B8%20%D1%81%D0%B0%D1%80%D0%BA%D0%BE%D0%BC%D1%8B%20%D0%BC%D0%B0%D1%82%D0%BA%D0%B8.pdf. Ссылка активна на 15.07.2022 [Klinicheskie rekomendatsii. Rak tela matki i sarkomy matki. Moscow: Minzdrav Rossii, 2021. Available at: https://rrcrst.ru/content/klinicheskie-rekomendaczii/%D0%A0%D0%B0%D0%BA%20%D1%82%D0%B5%D0%BB%D0%B0%20%D0%BC%D0%B0%D1%82%D0%BA%D0%B8%20%D0%B8%20%D1%81%D0%B0%D1%80%D0%BA%D0%BE%D0%BC%D1%8B%20%D0%BC%D0%B0%D1%82%D0%BA%D0%B8.pdf. Accessed: 15.07.2022 (in Russian)].
- Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983;15(1):10-7. doi: 10.1016/0090-8258(83)90111-7
- Trabert B, Wentzensen N, Felix AS, et al. Metabolic syndrome and risk of endometrial cancer in the united states: a study in the SEER-medicare linked database. Cancer Epidemiol Biomarkers Prev. 2015;24(1):261-7. doi: 10.1158/1055-9965.EPI-14-0923
- Van den Bosch T, Coosemans A, Morina M, et al. Screening for uterine tumours. Best Pract Res Clin Obstet Gynaecol. 2012;26(2):257-66. doi: 10.1016/j.bpobgyn.2011.08.002
- Arem H, Park Y, Pelser C, et al. Prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients. J Natl Cancer Inst. 2013;105(5):342-9. doi: 10.1093/jnci/djs530
- Ding D-C, Chen W, Wang J-H, Lin S-Z. Association between polycystic ovarian syndrome and endometrial, ovarian, and breast cancer: A population-based cohort study in Taiwan. Medicine (Baltimore). 2018;97(39):e12608. doi: 10.1097/MD.0000000000012608
- Hardiman P, Pillay OC, Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. Lancet. 2003;361(9371):1810-2. doi: 10.1016/s0140-6736(03)13409-5
- Gracia C, Woodruff TK, editors. Oncofertility Medical Practice. Clinical Issues and Implementation. Berlin: Springer, 2012. doi: 10.1111/aogs.12053
- Новикова Е.Г., Чулкова О.В., Пронин С.М. Предрак и начальный рак эндометрия у женщин репродуктивного возраста. М.: МИА, 2005 [Novikova EG, Chulkova OV, Pronin SM. Predrak i nachal'nyi rak endometriia u zhenshchin reproduktivnogo vozrasta. Moscow: MIA, 2005 (in Russian)].
- Чулкова О.В., Новикова Е.Г., Пронин С.М. Органосохраняющее и функционально щадящее лечение начального рака эндометрия. Опухоли женской репродуктивной системы. 2007;1-2:50-3 [Chulkova OV, Novikova EG, Pronin SM. Organ-preserving and functionally sparing therapy for early endometrial cancer. Tumors of female reproductive system. 2007;1-2:50-3 (in Russian)].
- Mazzon I, Corrado G, Masciullo V, et al. Conservative surgical management of stage IA endometrial carcinoma for fertility preservation. Fertil Steril. 2010;93:1286-9. doi: 10.1016/j.fertnstert.2008.12.009
- Corzo C, Santillan NB, Westin SN, Ramirez PT. Updates on conservative management of endometrial cancer. J Minim Invasive Gynecol. 2018;25(2):308-13. doi: 10.1016/j.jmig.2017.07.022
- Tock S, Jadoul P, Squifflet JL, et al. Fertility Sparing Treatment in Patients With Early Stage Endometrial Cancer, Using a Combination of Surgery and GnRH Agonist: A Monocentric Retrospective Study and Review of the Literature. Front Med (Lausanne). 2018;5:240. doi: 10.3389/fmed.2018.00240
- Chao A-S, Chao A, Wang C-J, et al. Obstetric outcomes of pregnancy after conservative treatment of endometrial cancer: case series and literature review. Taiwan J Obstet Gynecol. 2011;50(1):62-6. doi: 10.1016/j.tjog.2009.10.006
Supplementary files
